Treating severe COVID-19 associated secondary bacterial infections with Phage Therapy under the Declaration of Helsinki
Acronym
COVID-19_Phage
Description of the granted funding
Bacteriophages are viruses that infect and kill bacterial cells. SARS-Cov-2 infektion weakens the innate immune defense of lungs, which makes the patient susceptible to sometimes lethal bacterial pneumonia. Hospital acquired bacterial infections are often caused by pathogens that are resistant to antibiotics, which leaves very few treatment options. In the proposed project, we will isolate and prepare bacteriophages against the most problematic antibiotic resistant bacterial pathogens causing secondary infections in severe cases of COVID-19.
Show moreStarting year
2020
End year
2022
Granted funding
Role in consortium of the Academy of Finland
Leader
Other consortium parties
Funder
Research Council of Finland
Funding instrument
Targeted Academy projects
Other information
Funding decision number
336518
Research fields
Kliiniset lääketieteet
Themes
Lisätalousarvio III 2020
Identified topics
covid, pandemic, vaccines